A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
Introduction
Clinicians have observed for a long-time that schizophrenia patients are markedly prone to smoke tobacco (Lohr and Flynn, 1992). Although other severe psychiatric illnesses such as mood disorders are associated with tobacco smoking, the association between schizophrenia and tobacco smoking may be stronger (Hughes et al., 1986, de Leon et al., 1995, de Leon et al., 2002a, de Leon et al., 2003b, Diwan et al., 1998, LLerena et al., 2003). It has been suggested that biological factors may underlie the association between schizophrenia and tobacco smoking (Dalack et al., 1998, Freedman et al., 1997). This article explores the hypothesis that the association between schizophrenia and tobacco smoking is relatively independent of sociocultural factors and can be demonstrated across countries and cultures.
Section snippets
Methodological issues
A meta-analysis of studies conducted in different countries was performed to examine the above hypothesis. The rationale behind this review is that if an association between schizophrenia and tobacco smoking is observed in a variety of different cultures, then it is likely that a biological factor may underlie such association. Comparisons of schizophrenia patients with the general population and with other severe mentally ill patients were carried out. Schizoaffective patients were included in
Comparing current smoking in schizophrenia versus the general population
Table 1 describes 42 samples from 20 different nations and investigated a total of 7593 schizophrenia patients (62% were current smokers). Current smoking prevalences for schizophrenia patients were significantly higher than those for people from the general population, regardless of country, except in two studies: one from Japan, where current smoking prevalences in the general population are relatively high (particularly in males) and another from Colombia, where they are relatively low. The
Comparing heavy smoking among smokers with schizophrenia versus smokers from the general population
Table 6 describes 6 studies from 4 different countries. Although there was not a consistent definition of heavy smoking across these studies, the ORs were always significantly greater than 1, ranging between 1.9 and 6.4. This suggests that the odds that smokers with schizophrenia be heavy smokers are significantly greater than those of smokers from the general population. According to 3 studies, this conclusion may still be valid within males (Table 6) and according to 2 of 3 studies, this
High nicotine dependence among smokers
The FTND may reflect nicotine dependence and its brain disturbances better than heavy smoking. Unfortunately, very few studies of the association between schizophrenia and tobacco smoking have used the FTND (or its briefer version HSI). Etter et al. (2004) found that Swiss schizophrenia smokers had higher HSI scores than smokers from the Swiss general population.
Similarly a Spanish study (Gurpegui et al., 2005) found that 173 schizophrenia smokers had higher scores than 100 control smokers
Comparing smoking cessation rates among smokers with schizophrenia versus smokers from the general population
Six studies from 5 countries suggested that smoking cessation rates for schizophrenia patients were significantly smaller than the general population (Table 8). Combining these 6 studies, the cessation rate for schizophrenia patients was 9% versus cessation rates between 14% and 49% for the general population. The sample-size-weighted average of the ORs comparing cessation rates in schizophrenia smokers versus smokers from the general population was 0.19 (CI, 0.14–0.24).
Four studies suggested
Comparing ever smoking in schizophrenia versus the general population
In 8 out of the 9 studies described in Table 10, the OR comparing ever smoking in schizophrenia patients versus the general population was significantly greater than 1. The sample-size-weighted average of the 9 ORs was 3.1 (CI, 2.4–3.8). Only one study (Gurpegui et al., 2005) provided an adjusted OR after controlling for confounding variables, 1.4 (CI, 0.91–2.2) that did not reach significance.
Conclusions
A large number of worldwide studies describing current smoking in schizophrenia consistently suggest that schizophrenia patients from all countries share a biological factor that makes them more prone to smoke. Most studies examining ever smoking and two studies exploring age of smoking initiation (de Leon et al., 2002b, Gurpegui et al., 2005) suggest that there may be genetic factors increasing the risk of both becoming a smoker and developing schizophrenia. This model is supported by recent
Acknowledgements
Preliminary early versions of this article were presented by Dr. de Leon as lectures at John Umstead Hospital, Butner, NC on 8/29/02 and Burghölzli Hospital in Zurich, Switzerland on 7/12/03. Dr. Diaz was partially supported by the Dirección de Investigaciones of the Universidad Nacional, Medellin, Colombia (grants 030802738 and Apoyo a Grupos Reconocidos Colciencias 2004). Margaret T. Susce, R.N., M.L.T., and Maria Johnson, R.N., helped with editing of this article. Raimo K.R. Salokangas, MD,
References (111)
- et al.
Low prevalence of smoking in patients with autism spectrum disorders
Psychiatry Res.
(2003) - et al.
Factors affecting smoking in schizophrenia
Compr. Psychiatry
(2001) - et al.
The association between schizophrenia and cancer: a population-based mortality study
Schizophr. Res.
(2002) - et al.
Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia
Schizophr. Res.
(2000) - et al.
Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital
Schizophr. Res.
(2002) - et al.
Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders
Schizophr. Res.
(2002) - et al.
Exploring brief measures of nicotine dependence
Addict. Behav.
(2003) - et al.
Different prevalence of cigarette smoking in patients with schizophrenia vs. mood disorders
Schizophr. Res.
(1998) - et al.
Determinants of smoking behavior in outpatients with schizophrenia
Schizophr. Res.
(2000) - et al.
Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HIS
Drug Alcohol Depend.
(1994)
Schizophrenia and tobacco smoking in a Spanish psychiatric hospital
Schizophr. Res.
Smoking and schizophrenia
Schizophr. Res.
Repetitive behaviors in chronically institutionalized schizophrenic patients
Schizophr. Res.
Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences
Schizophr. Res.
Smoking habits in Japanese patients with schizophrenia
Psychiatry Res.
Addictive behaviors among hospitalized psychiatric patients
Addict. Behav.
Increased levels of nicotine metabolite cotinine in schizophrenic smokers compared to other smokers
Biol. Psychiatry
Assessing nicotine dependence: a comparison of the Fagerström Tolerance Questionnaire (FTQ) with the Fagerström Test for Nicotine Dependence (FTND) in a clinical sample
Addict. Behav.
Reliability of the Fagerström Tolerance Questionnaire and the Fagerström Test for Nicotine Dependence
Addict. Behav.
Prevalence of smoking in psychiatric patients
Prog. Neuro-psychopharmacol. Biol. Psychiatry
Reduced plasma antioxidants in first-episode patients with schizophrenia
Schizophr. Res.
Smoking in schizophrenia—all is not biological
Schizophr. Res.
Applicability of the Fagerstrom Test for Nicotine Dependence in smokers with schizophrenia
Addict. Behav.
Complex interactions between nicotine dependence and symptoms in schizophrenia: a naturalistic study
Br. J. Psychiatry
Smoking among male psychiatric outpatients in Saudi Arabia
Ann. Saudi Med.
Consumo y dependencia de drogas en la esquizophrenia
Actas Luso Esp. Neurol. Psiquiatr.
Pharmacologic aspects of cigarette smoking and nicotine addiction
N. Engl. J. Med.
Ethnic differences in N-glucuronidation of nicotine and cotinine
J. Pharmacol. Exp. Ther.
Nicotine dependence in the United States: prevalence, trends and smoking persistence
Arch. Gen. Psychiatry
The unhealthy lifestyle of people with schizophrenia
Psychol. Med.
La prevalenza del fumo di tabacco nei pazienti psichiatrici
Minerva Psichiatr.
Prevalencia de consumo de cigarrillo en pacientes de la consulta psiquiátrica de Bucaramanga
Colomb. Med.
Tabaquismo en pacientes psiquiátricos ambulatorios
Revista ABP-APAL
Severidad del tabaquismo en pacientes de la consulta psiquiátrica
Rev. Argent. Psiquiatr. Biol.
Anxiety and depressive symptoms among smokers: a population study
Medunab
Racial and ethnic differences in serum cotinine levels of cigarette smokers
JAMA
Prevalencia del consumo de cigarrillos en pacientes psiquiatricos
Acta Psiquiatr. Psicol. Am. Lat.
Statistical Inference
Cigarette smoking among adults—United States, 1992, and changes in the definition of current cigarette smoking
MMWR
Cigarette smoking among adults—United States, 1993
MMWR
State-specific prevalence among adults of current cigarette smoking and smokeless tobacco use and per capita tax-paid sales of cigarettes—United States, 1997
MMWR
State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoking—United States, 2000
MMWR
Level of activity and prevalence of smoking in psychiatric patients
Can. J. Psychiatry
Smoking and schizophrenic psychopathology
Am. J. Addict.
Smoking among Chinese patients with schizophrenia
Aust. N. Z. J. Psychiatry
Tobacco Control Country Profiles
Ever-smoking, quitting, and psychiatric disorders: evidence from the Durham, North Carolina, and Epidemiological Catchment Area
Tob. Control
Logxact-4 User Manual
Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings
Am. J. Psychiatry
Smoking and vulnerability for schizophrenia
Schizophr. Bull.
Cited by (1022)
Association between electronic nicotine product use and subsequent first episode psychosis
2024, Psychiatry ResearchA Network Model of Health-Related Changes after a Lifestyle-Enhancing Treatment in Patients with Severe Mental Illness: the MULTI Study VI
2024, International Journal of Clinical and Health PsychologyAdverse perinatal pregnancy outcomes in women with schizophrenia: A systematic review and meta-analysis
2023, Schizophrenia Research